Contrast-enhanced ultrasonography (CEUS) is increasingly being performed in Italy and Europe, particularly in the field of hepato-gastroenterology. Initially, it was mainly carried out to characterize focal hepatic lesions, but, since then, numerous studies have demonstrated its efficacy in the differential diagnosis of focal pancreatic pathologies (D’Onofrio et al. in Expert Rev Med Devices 7(2):257–273, 2010; Vidili et al. in J Ultrasound 22(1):41–51, 2019). The purpose of this paper is to provide Italian Medical Doctors with recommendations and thereby practical guidelines on the management of these patients. The present paper reports the final conclusions reached by the SIUMB guideline commission. This paper addresses particularly percutaneous ultrasound (US) examination (transabdominal US) and is drawn up specifically for publication.

Original languageEnglish
Pages (from-to)599-606
Number of pages8
JournalJournal of Ultrasound
Issue number4
Publication statusPublished - Dec 1 2020


  • CEUS
  • Contrast-enhanced ultrasound
  • Pancreas
  • Pancreatic adenocarcinoma
  • Pancreatic biopsy
  • Pancreatic cancer
  • Pancreatic cystic lesions
  • Ultrasound

ASJC Scopus subject areas

  • Internal Medicine
  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'SIUMB recommendations for focal pancreatic lesions'. Together they form a unique fingerprint.

Cite this